NCT00504712.

Methods	Randomised, double blind study.
Participants	Male, 18 years and older Type 2 diabetes mellitus. Serum testosterone 12 nmol/L or less on two consecutive samples taken on different days and symptoms compatible with hypogonadism. Peripheral vascular disease as defined by previous diagnosis by a specialist vascular surgeon or ABPI less than 0.92 and ischaemic leg pain (claudication or rest pain) or distal complications (non‐healing arterial foot ulcer or gangrene).
Interventions	Testosterone Sustanon, 200 mg intramuscular testosterone every 2 weeks Placebo 0.9% saline injection every two weeks
Outcomes	Primary outcome measures: change in arterial stiffness (time frame: 3 months)
Notes	Author was contacted, not yet published but forms part of MD thesis.